Idiopathic pulmonary fibrosis surgery

Jump to navigation Jump to search

Idiopathic pulmonary fibrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Idiopathic pulmonary fibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Idiopathic pulmonary fibrosis surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Idiopathic pulmonary fibrosis surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Idiopathic pulmonary fibrosis surgery

CDC on Idiopathic pulmonary fibrosis surgery

Idiopathic pulmonary fibrosis surgery in the news

Blogs on Idiopathic pulmonary fibrosis surgery

Directions to Hospitals Treating Idiopathic pulmonary fibrosis

Risk calculators and risk factors for Idiopathic pulmonary fibrosis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Lung transplantation is essential in treatment of patients with idiopathic pulmonary fibrosis. Pulmonary fibrosis is the most common interstitial lung disease requiring lung transplant and it should be performed early in order to increase the survival rate.

Indications

Indications of lung transplantation include:

  • Patients younger than 65 years old
  • Patients with low body mass index (<26 kg/m2)

Surgery

Lung transplantation

  • Lung transplantation is essential in treatment of patients with idiopathic pulmonary fibrosis. Pulmonary fibrosis is the most common interstitial lung disease requiring lung transplant and it should be performed early in order to increase the survival rate.[1]
  • Time of referral to lung transplantation: [2]
    • Confirmed histopathologic or radiographic findings of usual interstitial pneumonitis (UIP) regardless of lung function
    • Forced vital capacity (FVC) <80% predicted
    • Diffusion capacity of the lung for carbon monoxide (DLCO) <40% predicted.
    • Lung functional limitation (eg, dyspnea)
  • Time of listing:[3]

References

  1. Thabut G, Mal H, Castier Y, Groussard O, Brugière O, Marrash-Chahla R; et al. (2003). "Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis". J Thorac Cardiovasc Surg. 126 (2): 469–75. PMID 12928646.
  2. Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S; et al. (2015). "A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation". J Heart Lung Transplant. 34 (1): 1–15. doi:10.1016/j.healun.2014.06.014. PMID 25085497.
  3. Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S; et al. (2015). "A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation". J Heart Lung Transplant. 34 (1): 1–15. doi:10.1016/j.healun.2014.06.014. PMID 25085497.

Template:WH Template:WS [[Category:Primary Care]